Wet Age-Related Macular Degeneration (Wet AMD) Market 2023: Epidemiology, Trends

1. Wet Age-Related Macular Degeneration (Wet AMD)Market Research Report 2023-2033

2. ABOUT IMARC International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most criticalchallenges,and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations,and secure lasting results. 2

3. Report Description and Highlights Wet WetAge Age- -Related RelatedMacular MacularDegeneration Degeneration(Wet (WetAMD) AMD)Market Market2023 2023- -2033 2033 The newly published report by IMARC Group, titled, ”Wet ”Wet Age Age- -Related Related Macular Macular Degeneration Degeneration (Wet (Wet AMD) AMD) Market Market: : Epidemiology, Epidemiology, Industry Industry Trends, Trends, Share, Share, Size, Size, Growth, Growth, Opportunity, Opportunity, and and Forecast Forecast 2023 2023- -2033 2033″ ″, , presents a comprehensive analysis of the wet age-related macular degeneration (Wet AMD) market. The report provides an overview of the market trends, growth prospects, investment opportunities, and industry prospects, as well as an analysis of the disease overview, market scenario, and growth trends. In addition, the report offers competitor analysis, regional analysis, and recent advancements in the global market. The report also highlights key segments and market drivers, as well as challenges faced by industry players. Wet age-related macular degeneration (Wet AMD) represents an eye disease that destroys the macula. It usually involves the growth of abnormal blood vessels under the macula that leak blood and fluids into layers of the retina. The symptoms of wet age-related macular degeneration start suddenly and are generally severe. It can cause vision loss but does not lead to total blindness, as the patients can retain their side vision. In addition to this, wet age-related macular degeneration makes it extremely hard for individuals to do their daily things and can negatively impact the quality of their life. Some of the commonly utilized techniques for treating the disease are photodynamic laser therapies, anti-VEGF medications, anti-angiogenic drugs, etc. 3

4. Report Description and Highlights Wet Wet Age Age- -Related RelatedMacular MacularDegeneration Degeneration(Wet (WetAMD) AMD)Market MarketTrend Trend: : The expanding geriatric population and the growing incidences of chronic blindness are primarily driving the wet age-related macular degeneration (Wet AMD) market. Additionally, sedentary lifestyles and changing dietary patterns of individuals are increasing the prevalence of this eye disease, which is further catalyzing the market growth. Besides this, continuous improvements in diagnosis and drug treatment rates are acting as significant growth-inducing factors. Moreover, the launch of several favorable policies by government bodies to spread awareness among patients regarding numerous available treatment options is positively influencing the global market. Apart from this, the rising technological advancements in the healthcare industry and extensive investments in R&D activities are also stimulating the market growth. Furthermore, the development of innovative and effective medications is anticipated to fuel the wet age- related macular degeneration (Wet AMD) market over the forecasted period. Request a Free Sample Report: https://www.imarcgroup.com/wet-age-related-macular-degeneration-market/requestsample 4

5. Report Description and Highlights Report Period: Report Period: • Base Year: 2022 • Historical Period: 2017-2022 • Market Forecast: 2023-2033 Countries Included: Countries Included: • United States • Germany • France • United Kingdom • Italy • Spain • Japan 5

6. Report Description and Highlights Analysis AnalysisCovered CoveredAcross AcrossEach EachCountry Country • Historical, current, and future epidemiology scenario • Historical, current, and future performance of the vertigo market • Historical, current, and future performance of various therapeutic categories in the market • Sales of various drugs across the vertigo market • Reimbursement scenario in the market • In-market and pipeline drugs In In- -Market MarketDrugs Drugs • Drug Overview • Mechanism of Action • Regulatory Status • Clinical Trial Results • Drug Uptake and Market Performance 6

7. Report Description and Highlights Late Late- -Stage StagePipeline PipelineDrugs Drugs • Drug Overview • Mechanism of Action • Regulatory Status • Clinical Trial Results • Regulatory Status • View ViewReport ReportTOC, TOC,Figures Figuresand andTables Tables: https://www.imarcgroup.com/wet-age-related-macular-degeneration-market 7

8. Key Questions Answered in the Report 1. 1. How has the Wet Age How has the Wet Age- -Related Macular Degeneration (Wet AMD) market performed so far and how will it perform in the coming years? Related Macular Degeneration (Wet AMD) market performed so far and how will it perform in the coming years? 2. 2. What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033? What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033? 3. 3. What was the country What was the country- -wise size of the Wet Age wise size of the Wet Age- -Related Macular Degeneration (Wet AMD) market across the seven major markets in Related Macular Degeneration (Wet AMD) market across the seven major markets in 2022 and what will it look like in 2033? 2022 and what will it look like in 2033? 4. 4. What is the growth rate of the Wet Age What is the growth rate of the Wet Age- -Related Macular Degeneration (Wet AMD) market across the seven major markets and what wil Related Macular Degeneration (Wet AMD) market across the seven major markets and what will l be the expected growth over the next ten years? be the expected growth over the next ten years? 5. 5. What are the key unmet needs in the market? What are the key unmet needs in the market? 8

9. Table of Contents

10. Table of Contents • 1 Preface 1 Preface • 2 Scope and Methodology 2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology • 3 3 Executive Summary Executive Summary 4 Wet Age 4 Wet Age- -Related Macular Degeneration Related Macular Degeneration - - Introduction 4.1 Overview 4.2 Epidemiology (2017-2022) and Forecast (2023-2033) Introduction 10

11. Table of Contents • 4.3 Market Overview (2017-2022) and Forecast (2023-2033) 4.4 Competitive Intelligence • 5 Wet Age 5 Wet Age- -Related Macular Degeneration Related Macular Degeneration - - Disease Overview 5.1 Introduction 5.2 Symptoms and Diagnosis 5.3 Pathophysiology 5.4 Causes and Risk Factors 5.5 Treatment Disease Overview • 6 Patient Journey 6 Patient Journey Click here to visit the complete table of content with list of figures and tables Click here to visit the complete table of content with list of figures and tables: https://www.imarcgroup.com/wet-age-related-macular- degeneration-market/toc 11

12. Partial List Of Our Clients 12

13. OUR CLIENTS 13

14. Disclaimer © 2023 2023 IMARC IMARCAll All Rights Rights Reserved Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer Disclaimer: : All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies. 14